Finalization of the Project: Creation of an Open Scientific Repository of Stem Cells Derived from Individuals with ARCA1-type Ataxia

The Ataxia Canada Foundation thanks CDPQ for the financial support provided to the research. This project aimed to reprogram patient-derived cells into induced pluripotent stem cells (iPSC) for the study of ARCA1, a disease for which there is a significant lack of representative cellular models. Impact of this Research: Specific...

Continue reading

New Gene Therapy Study in Friedreich’s Ataxia (FA) Sponsored by LEXEO Therapeutics, Inc

The study is being conducted with multiple sites in the United States and Canada seeking to recruit approximately 9 participants aged 18-40 with a diagnosis of FA-associated cardiomyopathy. The study will be conducted by Dr. Antoine Duquette at the CHUM in Montreal. The choice of Montreal as a site reflects...

Continue reading

Research grant 2020

Since its inception, the Ataxia Canada Foundation has had the mission of supporting research to contribute to the development of therapies targeting both the causes and the effects of different forms of ataxia. The pursuit of this objective is still very much alive within the administration and the members of the Foundation. Research funded by...

Continue reading